Copyright
©The Author(s) 2016.
World J Hepatol. Dec 8, 2016; 8(34): 1502-1510
Published online Dec 8, 2016. doi: 10.4254/wjh.v8.i34.1502
Published online Dec 8, 2016. doi: 10.4254/wjh.v8.i34.1502
Figure 1 Outcome of patients with bilobar colorectal liver metastases in this study.
CRLM: Colorectal liver metastases.
Figure 2 Overall survival of patients with bilobar colorectal liver metastases in this study.
All patients (n = 136): 18 (1-48) mo.
Figure 3 Difference in overall survival in patients that underwent surgery, down-staging therapy followed by surgery or palliative therapy and inoperable patients.
Figure 4 Difference in overall survival in patients that underwent surgery following down-staging therapy compared to patients that either failed down-staging therapy or were treated with palliative therapy.
Figure 5 Difference in disease-free survival in patients with R0 resection compared to patients with R1 resection.
Figure 6 Difference in overall survival in patients with R0 resection compared to patients with R1 resection.
Figure 7 Difference in overall survival in female patients compared to male patients following surgery for colorectal liver metastases.
- Citation: Di Carlo S, Yeung D, Mills J, Zaitoun A, Cameron I, Gomez D. Resection margin influences the outcome of patients with bilobar colorectal liver metastases. World J Hepatol 2016; 8(34): 1502-1510
- URL: https://www.wjgnet.com/1948-5182/full/v8/i34/1502.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i34.1502